In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.
The Telegraph reports that philosopher Jeremy Bentham is to have his DNA tested.
Researchers have increased their estimate of the heritability of ASD to 83 percent based on a reanalysis of their prior study of Swedish families.
The grants include awards for projects using genetics to identify differences in how ASD affects boys versus girls, and how to improve treatments.
Researchers found 7 percent of mutations in children's DNA could be traced to postzygotic mosaic mutations present early in their parents' embryonic development.
Investigators identified ties between autism spectrum disorder and mitochondrial haplogroups in mtDNA variant data from nearly 1,000 ASD-affected families.
In PNAS this week: deep evolutionary conservation of autism-linked genes, cytokine signature of chronic fatigue syndrome, and more.
The company is collaborating with hospitals to implement sequencing and machine learning approaches to pinpoint the molecular etiology of autism earlier in age.
In PNAS this week: analytical method for assessing shared variants, treatment targets in hereditary pancreatic cancer, and more.
Spectrum News reports that a group has uncovered a statistical flaw in a recent paper linking new genes to autism or developmental delay.
An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.
An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.
In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.
Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.